Cullinan Therapeutics, Inc. (NASDAQ:CGEM – Get Free Report) fell 4.5% on Tuesday . The company traded as low as $22.99 and last traded at $23.05. 266,559 shares traded hands during trading, a decline of 58% from the average session volume of 630,100 shares. The stock had previously closed at $24.13. Wall Street Analysts Forecast Growth […]
Shares of Iovance Biotherapeutics, Inc. (NASDAQ:IOVA – Get Free Report) have been given an average recommendation of “Buy” by the ten ratings firms that are currently covering the firm, MarketBeat Ratings reports. Ten investment analysts have rated the stock with a buy recommendation. The average 1-year price target among analysts that have issued a report […]
Bernzott Capital Advisors lessened its holdings in Viper Energy, Inc. (NASDAQ:VNOM – Free Report) by 19.7% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 227,825 shares of the oil and gas producer’s stock after selling 55,813 shares during […]
StockNews.com upgraded shares of Aptose Biosciences (NASDAQ:APTO – Free Report) (TSE:APS) from a sell rating to a hold rating in a report released on Tuesday. APTO has been the topic of a number of other reports. Piper Sandler reissued an overweight rating and issued a $5.00 price target on shares of Aptose Biosciences in a […]
StockNews.com upgraded shares of Aptose Biosciences (NASDAQ:APTO – Free Report) (TSE:APS) from a sell rating to a hold rating in a research report report published on Tuesday. Several other analysts also recently commented on the company. Piper Sandler restated an overweight rating and issued a $5.00 target price on shares of Aptose Biosciences in a […]